Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Solomon To Step Aside As Forest Exec; Icahn Wins Another Victory

May 23 2013

• By Stacy Lawrence

Related Content

Sanofi Claims Genzyme With $20.1 Billion Upfront And CVRs

Feb 21 2011

HHS Office of Inspector General Drops Challenge To Forest CEO Solomon

Aug 05 2011

Many New Products For Forest, But Not Enough To Fill The <em>Lexapro</em> Gap

Apr 23 2013

Carl Icahn’s Partial Victory In Battle For Forest: One Board Seat

Aug 15 2012

Forest Takes Over <em>Namenda</em> Lifecycle-Management Project In Deal With Adamas

Nov 14 2012

Icahn Tries To Rain On Genzyme's Investor Day Parade With Proxy Seeking Termeer's Ouster

May 06 2010

Related Companies

Forest Laboratories, Inc.

Astellas Pharma, Inc.

Enzon Pharmaceuticals, Inc.

Vivus, Inc.

Additional Topics

Strategy Business Strategies Leadership BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window